Skip to main content
TipRanks
Go Ultimate75% OFF

Lexeo Therapeutics, Inc. (LXEO) Hedge Fund Trading Activity

311 Followers
Trend: ▲ Hedge Funds Increased Holdings by 580.0K Shares Last Quarter

Hedge Fund Holdings in LXEO

0.00$1.505.00M$4.0010.00M$6.5015.00M$9.0020.00M$11.50Jan '25Jul '25Jan '26Jul '26$2.86Stock PriceShares Held by Hedge Funds

Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.

Hedge Fund Confidence Signal

Unlock Hedge Fund Confidence Signal

Hedge Fund Activity​

Activity
Star Ranking
Hedge fund activity
Kenneth Tropin hedge funds manager, Graham Capital Management, L.P.,Rank 66Kenneth TropinGraham Capital Management, L.P.New100.00%$139,733<0.01%
Andrew Alkon hedge funds manager, EntryPoint Capital, LLC,Rank 360Andrew AlkonEntryPoint Capital, LLCAdded16.71%$408,8680.10%
BlackRock, Inc. hedge funds manager,  ,Rank 334BlackRock, Inc. Added4.08%$20,190,819<0.01%
Michael Rockefeller hedge funds manager, Woodline Partners LP,Rank 459Michael RockefellerWoodline Partners LPAdded0.09%$8,459,6570.03%
Peter Kolchinsky hedge funds manager, RA Capital Management,Rank 27Peter KolchinskyRA Capital ManagementNot Changed0.00%$16,900,0000.15%
Stephen A. Schwarzman hedge funds manager, Blackstone Inc.,Rank 97Stephen A. SchwarzmanBlackstone Inc.Not Changed0.00%$3,058,761<0.01%
Ken Fisher hedge funds manager, Fisher Asset Management LLC,Rank 39Ken FisherFisher Asset Management LLCNot Changed0.00%$386,408<0.01%

FAQ

Which hedge funds hold Lexeo Therapeutics, Inc.?
The hedge funds that hold the most shares in Lexeo Therapeutics, Inc. are BlackRock, Inc., Ken Fisher and Andrew Alkon.
Are hedge funds buying or selling LXEO?
In the last quarter hedge funds have Increased their holdings in Lexeo Therapeutics, Inc. by 580.0K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Lexeo Therapeutics, Inc. stock?
Warren Buffet currently does not own shares in Lexeo Therapeutics, Inc..
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here